share_log

InMed Pharmaceuticals Announces INM-901 As An Oral Formula That Will Be Used In Its Development Programs For Alzheimer's Disease

Benzinga ·  Aug 20 19:37
InMed Pharmaceuticals Announces INM-901 As An Oral Formula That Will Be Used In Its Development Programs For Alzheimer's Disease
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment